A study performed in melanoma using the same adenoviral vector with interleukin-2 instead of interferon-γ showed regression of metastatic melanoma lesions in 6 out of 21 patients treated at the same dose of 3.10 [12] viral particles (vp) by injection [13]. Here, IL2 is linked to melanoma.